Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1171-1180 of 9364

Page
per page
  1. K-252c
    A8344 K-252c
    Target: PKC|PKA
    Summary: Protein kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.55 mg/mL
  2. BYL-719
    A8346 BYL-719
     1 Citation
    Target: PI3K
    Summary: Selective PI3Kα inhibitor
      ≥22.07 mg/mL
  3. Pazopanib Hydrochloride
    A8347 Pazopanib Hydrochloride
    Summary: VEGFR/PDGFR/FGFR/c-Kit/ c-Fms inhibitor
      ≥11.1 mg/mL
  4. 3-Methyladenine
    A8353 3-Methyladenine
     41 Citation
    Target: PI3K
    Summary: Class III PI3K inhibitor
      ≥5 mg/mL
  5. A66
    A8354 A66
    Target: PI3K
    Summary: P110α inhibitor
      insoluble in H2O; ≥19.7 mg/mL
  6. Acetarsone
    A8355 Acetarsone
    Summary: An organoarsenic compound
      insoluble in H2O; insoluble in EtOH; ≥12.95 mg/mL
  7. Acetylcysteine
    A8356 Acetylcysteine
    Summary: Antioxidant;mucolytic agent
      ≥44.6 mg/mL
  8. AG-1478
    A8357 AG-1478
    Target: EGFR
    Summary: EGFR inhibitor,potent and selective
      insoluble in H2O; ≥15.8 mg/mL
  9. Albendazole
    A8358 Albendazole
    Summary: treatment of a variety of parasitic worm infestations
      insoluble in EtOH; insoluble in H2O; ≥8.75 mg/mL
  10. Alendronate sodium
    A8359 Alendronate sodium
    Summary: Osteoclast-mediated bone resorption inhibitor
      insoluble in DMSO; insoluble in EtOH; ≥15 mg/mL

Items 1171-1180 of 9364

Page
per page